{
  "ticker": "PYXS",
  "company_name": "Pyxis Oncology, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT06795412",
      "title": "Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors",
      "status": "RECRUITING",
      "phase": "PHASE1, PHASE2",
      "condition": "Advanced Solid Tumours",
      "start_date": "2025-04-15",
      "completion_date": "2027-12-06",
      "enrollment": 0,
      "sponsor": "Pyxis Oncology, Inc"
    },
    {
      "nct_id": "NCT05720117",
      "title": "Study of PYX-201 in Solid Tumors",
      "status": "RECRUITING",
      "phase": "PHASE1",
      "condition": "Solid Tumor, Advanced Solid Tumor",
      "start_date": "2023-03-14",
      "completion_date": "2027-05",
      "enrollment": 0,
      "sponsor": "Pyxis Oncology, Inc"
    },
    {
      "nct_id": "NCT05718557",
      "title": "Study of PYX-106 in Solid Tumors",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE1",
      "condition": "Solid Tumor",
      "start_date": "2023-05-23",
      "completion_date": "2026-05",
      "enrollment": 0,
      "sponsor": "Pyxis Oncology, Inc"
    },
    {
      "nct_id": "NCT03389802",
      "title": "Phase I Study of APX005M in Pediatric Central Nervous System Tumors",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE1",
      "condition": "Glioblastoma Multiforme, High-grade Astrocytoma Not Otherwise Specified (NOS), CNS Primary Tumor, Not Otherwise Specified (NOS), Ependymoma, Not Otherwise Specified (NOS), Diffuse Intrinsic Pontine Gliomas (DIPG), Medulloblastoma",
      "start_date": "2018-03-01",
      "completion_date": "2025-11-01",
      "enrollment": 0,
      "sponsor": "Pediatric Brain Tumor Consortium"
    },
    {
      "nct_id": "NCT02706353",
      "title": "APX005M in Combination With Systemic Pembrolizumab in Patients With Metastatic Melanoma",
      "status": "TERMINATED",
      "phase": "PHASE1, PHASE2",
      "condition": "Melanoma",
      "start_date": "2017-06-02",
      "completion_date": "2025-03-10",
      "enrollment": 0,
      "sponsor": "M.D. Anderson Cancer Center"
    }
  ],
  "summary": {
    "total_trials": 5,
    "by_phase": {
      "PHASE1, PHASE2": 2,
      "PHASE1": 3
    },
    "by_status": {
      "RECRUITING": 2,
      "ACTIVE_NOT_RECRUITING": 2,
      "TERMINATED": 1
    },
    "active_trials": 4,
    "completed_trials": 0,
    "conditions": [
      "Advanced Solid Tumours",
      "Glioblastoma Multiforme, High-grade Astrocytoma Not Otherwise Specified (NOS), CNS Primary Tumor, Not Otherwise Specified (NOS), Ependymoma, Not Otherwise Specified (NOS), Diffuse Intrinsic Pontine Gliomas (DIPG), Medulloblastoma",
      "Melanoma",
      "Solid Tumor",
      "Solid Tumor, Advanced Solid Tumor"
    ],
    "lead_stage": "phase_1"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:21:09.759184",
    "search_query": "Pyxis Oncology, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Pyxis+Oncology,+Inc."
  }
}